🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

OSI Systems' Spacelabs division secures $6 million hospital contract

Published 2024-04-09, 09:18 a/m
OSIS
-

HAWTHORNE, Calif. - OSI Systems , Inc. (NASDAQ:OSIS) announced today that its Spacelabs Healthcare division has received a $6 million order from a U.S. hospital for patient monitoring solutions, including Xhibit Central Stations, Xprezzon patient monitors, and Qube patient monitors, along with related accessories. This order marks a significant step for the company in supporting healthcare infrastructure enhancements.

Deepak Chopra, OSI Systems' Chairman, and CEO, expressed the company's pleasure in obtaining the substantial order and emphasized their commitment to delivering advanced patient monitoring solutions essential for superior patient care.

OSI Systems, a provider of specialized electronic systems for critical applications in security, healthcare, defense, and aerospace, leverages over 40 years of engineering and manufacturing expertise. With a global presence, the company pursues a strategic expansion into selective markets through its various subsidiaries.

The information discussed in this article is based on a press release statement from OSI Systems, Inc.

InvestingPro Insights

OSI Systems, Inc. (NASDAQ:OSIS) has been showcasing robust financial performance along with its strategic achievements in the healthcare sector. With a market capitalization of $2.43 billion, the company's dedication to innovation in patient monitoring solutions is reflected not just in its recent $6 million order but also in its financial growth. Over the last twelve months leading up to Q2 2024, OSI Systems has seen a healthy revenue growth of 14.8%, and an even more impressive quarterly revenue growth of 26.26%, underscoring the company's expanding market presence and operational efficiency.

InvestingPro data indicates that the company's gross profit margin stands at a strong 35.61%, which suggests that OSI Systems is proficient in managing its production costs and scaling its business operations effectively. Additionally, the company's stock has been trading near its 52-week high, with the price reaching 98.76% of this peak, a sign that investor confidence may be high in the company's market performance and future outlook.

Among the InvestingPro Tips, it's noteworthy that OSI Systems is trading at a high P/E ratio relative to near-term earnings growth, which investors often interpret as an expectation of higher future growth. Also, the company's stock generally trades with low price volatility, which could indicate a stable investment for those looking at a less turbulent market experience. For those interested in deeper analysis, there are 6 additional InvestingPro Tips available for OSI Systems, which can be accessed on InvestingPro's platform.

Investors looking to explore these insights further can take advantage of a special offer using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro. This offer can help investors make more informed decisions by providing a comprehensive analysis of OSI Systems' performance and potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.